Phase 2 ASCEND trial of solengepras, a novel, non-dopaminergic GPR6 inhibitor, showed evidence of potential benefit in ...

This review analyzes nearly three decades of research on menstrual cycle phases and their inconsistent effects on women's ...

Bial, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today announced a ...

Phase 2 randomized, double-blind, placebo-controlled trial planned to evaluate TNX-2900 in children and adolescents (ages 8 to 17.5 years) with ...

SPRINGFIELD, Mo. (KY3) - We’re just a couple of weeks away from the opening of Phase Two of the Kansas Expressway, which will connect the road to Cox Road at Farm Road 190 in Springfield, where a new ...

If you’re concerned, start documenting. Kuntzman recommends tracking: day, time, location, what happened five minutes before, ...

Revolutionary technology could transform how amputees experience artificial limbs through restored sense of touch.

Jaeger-LeCoultre’s new Master Control Calendar proves that when it comes to watches, two shades of grey are more than enough ...

Phase 2 randomized, double-blind, placebo-controlled trial planned to evaluate TNX-2900 in children and adolescents (ages 8 to 17.5 years) with Prader-Willi Syndrome under a cleared IND TNX-2900 grant ...

The INTREPID study group, a team of 49 researchers from 30 academic and medical institutions, reports on sustained five-year ...

AMT-130 was generally well-tolerated, with a manageable safety profile at both doses. As of June 30, 2025, no new drug-related serious adverse events have been observed since December 2022. The most ...